13063_2017_1812_MOESM4_ESM.pdf (204.97 kB)
Additional file 4: of Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
journal contribution
posted on 2017-03-07, 05:00 authored by Amy Cranston, Deborah Stocken, Elaine Stamp, David Roblin, Julia Hamlin, James Langtry, Ruth Plummer, Alan Ashworth, John Burn, Neil RajanPictorial overview of phase 2a design. (PDF 152 kb)